Davadost Pharma Private Limited
About Davadost Pharma Private Limited
Data last updated: 31 December 2025
Davadost Pharma Private Limited is a private limited company based in Kolkata, West Bengal, India, recognised as a startup by DPIIT. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 19 August 2014, the company has been in operation for over 12 years.
Registered with ROC Kolkata under CIN U74900WB2014PTC203164.
Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹82.33 Lakh. Formerly known as Oakwood Consulting Private Limited. It is led by directors including Nikita Choudhary and Sunil Rewachand Chandiramani.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 2 Ho – Chi – Minh Sarani, Kolkata, West Bengal, India – 700071.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.96 Cr, a growth of 25% compared to the previous year.
The company has a workforce of approximately 159 employees as per the latest available data.
The company is associated with 1 brand - Dawaa Dost. As per MCA filings, the company has open charges of ₹23.52 Lakh and satisfied charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered Address2 Ho – Chi – Minh Sarani, Kolkata, West Bengal, India – 700071
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Davadost Pharma Private Limited
Davadost Pharma Private Limited has one previous CIN (Corporate Identification Number): U74900WB2014PTC203164. The current CIN is U51100WB2014PTC203164, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51100WB2014PTC203164 | Current |
| U74900WB2014PTC203164 | Previous |
Associated Brands with Davadost Pharma Private Limited
Davadost Pharma Private Limited operates one associated brand: Dawaa Dost. These brands represent Davadost Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Online pharmacy providing generic medicines, personal care, and health products | dawaadost.com |
Competitors & Alternatives of Davadost Pharma Private Limited
Brands and companies operating in the same space as Davadost Pharma Private Limited include Tata 1mg, SastaSundar, PharmEasy and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Provider of an online pharmacy with doctor listing and teleconsultation services | Delhi, India, India | 2015 |
|
|
An online marketplace for healthcare products is operated. | Kolkata, India, India | 2011 |
|
|
Provider of an online pharmacy and healthcare platforms | Mumbai, India, India | 2015 |
|
|
Medicines and health products are retailed through pharmacy outlets. | Hyderabad, India, India | 2006 |
|
|
Provider of an online pharmacy and telehealth platform | Mumbai, India, India | 2019 |
|
|
Provider of an online store for medicines and healthcare products | Chennai, India, India | 2015 |
|
|
Provider of an online pharmacy for medications | Bengaluru, India, India | 2014 |
|
|
Online platform for the purchase of medicines | Kolkata, India, India | 2018 |
Business Activity of Davadost Pharma Private Limited
Davadost Pharma Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | ********* |
Board of Directors of Davadost Pharma Private Limited
Davadost Pharma Private Limited is currently managed by 6 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikita Choudhary | Director | 19 Aug 2014 | 11 Years 10 Months | Current |
|
Sunil Rewachand Chandiramani
Also directs:
Nyka Advisory Services Llp, Ganesh Consumer Products Limited, Rupa & Company Ltd and 5 more
|
Director | 07 Apr 2020 | 6 Years 3 Months | Current |
|
Sundeep Bajoria
Also directs:
Coca Cola India Private Limited
|
Additional Director | 09 Apr 2025 | 1 Years 3 Months | Current |
|
Amit Choudhary
Also directs:
Updater Services Limited, Waterlillies Infinite Llp, Ninenine Consumer Private Limited and 4 more
|
Director | 10 Oct 2018 | 7 Years 8 Months | Current |
|
Yash Harlalka
Also directs:
Anvaya Growth Llp, Ninenine Consumer Private Limited, Dawaa Dost Retail Private Limited and 1 more
|
Director | 04 Oct 2021 | 4 Years 9 Months | Current |
| Punit Kumar Poddar | Director | 28 Oct 2019 | 6 Years 8 Months | Current |
Financials of Davadost Pharma Private Limited FY 2025 filings available
Davadost Pharma Private Limited reported revenue of ₹64.96 Cr (up 25% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Davadost Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Oct 2022 | Hdfc Bank Limited | ₹23.52 Lakh | Open |
| 24 Mar 2022 | Others | ₹50 Lakh | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Davadost Pharma Private Limited
View historical data on people associated with Davadost Pharma Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Davadost Pharma Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Davadost Pharma Private Limited
GSTIN & GST Filing Data of Davadost Pharma Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Davadost Pharma Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Davadost Pharma Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Davadost Pharma Private Limited
MSME Payment Delays by Davadost Pharma Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Davadost Pharma Private Limited
Subsidiaries & Group Companies of Davadost Pharma Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Davadost Pharma Private Limited with ownership details.
MCA Filings & Documents of Davadost Pharma Private Limited
MCA Filings & Documents of Davadost Pharma Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Davadost Pharma Private Limited
Frequently Asked Questions about Davadost Pharma Private Limited
Davadost Pharma Private Limited is an active private limited company in the pharma sector based in Kolkata, West Bengal, India. It was incorporated on 19 August 2014 (12+ years old) and is registered under CIN U51100WB2014PTC203164. The company has 159 employees.
Davadost Pharma Private Limited reported revenue of ₹64.96 Cr for FY 2025 (up 25.00% YoY).
The current directors of Davadost Pharma Private Limited are:
The primary industry of Davadost Pharma Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Yes, Davadost Pharma Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Davadost Pharma Private Limited can be reached at the registered office: 2 Ho – Chi – Minh Sarani, Kolkata, West Bengal, India – 700071.